Carta al Director
Some clarifications regarding botulinum toxin type A units. Reply
H. Alonso-Navarro, F. J. Jiménez-Jiménez, J.F. Plaza-Nieto, B. Pilo-de-la-Fuente, F. Navacerrada, M. Arroyo-Solera, M. Calleja [REV NEUROL 2012;54:319] PMID: 22362483 DOI: https://doi.org/10.33588/rn.5405.2011682 OPEN ACCESSVolumen 54 | Number 05 | Nº of views of the article 3.678 | Nº of PDF downloads 335 | Article publication date 01/03/2012